Caryn Etsuko Shima Oshiro

Dr. Caryn Etsuko Shima Oshiro


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Cancer Prevention Research
Verified
Journal Article
Open access
PDF file
KRKatharine A. Rendle
Katharine A. Rendle
ABAndrea N. Burnett-Hartman
Andrea N. Burnett-Hartman
CNChristine Neslund-Dudas
Christine Neslund-Dudas
RGRobert T. Greenlee
Robert T. Greenlee
SHStacey Honda
Stacey Honda
DRDebra P. Ritzwoller
Debra P. Ritzwoller
Numerous organizations, including the United States Preventive Services Task Force, recommend annual lung cancer screening (LCS) with low-dose CT for high risk adults who meet specific criteria. Despite recommendations and national coverage for screening eligible adults through the Centers for Medicare and Medicaid Services, LCS uptake in the United States remains low (<4%). In recognition of the need to improve and understand LCS across the population, as part of the larger Population-based Research to Optimize the Screening PRocess (PROSPR) consortium, the NCI (Bethesda, MD) funded the Lung PROSPR Research Consortium consisting of five diverse healthcare systems in Colorado, Hawaii, Michigan, Pennsylvania, and Wisconsin. Using various methods and data sources, the center aims to examine utilization and outcomes of LCS across diverse populations, and assess how variations in the implementation of LCS programs shape outcomes across the screening process. This commentary presents the PROSPR LCS process model, which outlines the interrelated steps needed to complete the screening process from risk assessment to treatment. In addition to guiding planned projects within the Lung PROSPR Research Consortium, this model provides insights on the complex steps needed to implement, evaluate, and improve LCS outcomes in community practice.

15 March 2019 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
COCaryn Etsuko Shima Oshiro
Caryn Etsuko Shima Oshiro
TFTimothy B. Frankland
Timothy B. Frankland
ARA. Gabriela Rosales
A. Gabriela Rosales
NPNancy A. Perrin
Nancy A. Perrin
CBChristina L. Bell
Christina L. Bell
CTConnie M. Trinacty
Connie M. Trinacty

20 January 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
COCaryn Etsuko Shima Oshiro
Caryn Etsuko Shima Oshiro
TFTimothy B. Frankland
Timothy B. Frankland
JMJoanne Mor
Joanne Mor
CWCarmen P. Wong
Carmen P. Wong
YMYannica Theda Martinez
Yannica Theda Martinez
SHStacey Honda
Stacey Honda
Lung cancer is the leading cause of cancer deaths in both men and women in the US.1 As of this writing, the American Cancer Society estimates that there will be approximately 235 760 new lung cancer cases and 131 880 lung cancer deaths in 2021.2 In the 2016 Cancer Facts and Figures report,3 a special section on cancer incidence and mortality among Asian American, Native Hawaiian, and Pacific Islander (AANHPI) individuals highlighted the disproportional lung cancer incidence and mortality rates that exist among these racial and ethnic groups. Moreover, these differences may not be immediately apparent because cancer data on AANHPI individuals in the US has generally been presented in aggregate, masking differences in the cancer burden that exists within racial and ethnic subpopulations.3,4 Lung cancer is the leading cause of cancer-related mortality among men of all Asian American ethnicities and of Chinese, Filipino, and Japanese women.5 Chinese women (in Asia and the US) have high lung cancer rates even though the prevalence of smoking in this group is low.3 In Hawaii, lung cancer is among the most common cancers,6 with the highest lung cancer incidence in Native Hawaiian men and women (79.9 and 64.4 cases per 100 000, respectively) and Filipino men (71.7 cases per 100 000).7 The findings of these studies further emphasize the importance of disaggregating AANHPI racial and ethnic groups and by sex to tease apart true differences that may exist in lung cancer rates.

8 September 2021 in BMC Cancer
Verified
Journal Article
Open access
PDF file
JFJami Fukui
Jami Fukui
KWKami White
Kami White
TFTimothy B. Frankland
Timothy B. Frankland
COCaryn Etsuko Shima Oshiro
Caryn Etsuko Shima Oshiro
LWLynne R. Wilkens
Lynne R. Wilkens
Background: Weight changes are common among breast cancer patients. The majority of studies to date have focused on weight gain after a breast cancer diagnosis and its implications on health in survivors. Fewer studies have examined weight loss and its related characteristics. Weight changes have been reported to be influenced by several factors such as age, treatment, stage and pre-diagnostic weight. We evaluated weight changes during key treatment time points in early stage breast cancer patients. Methods: We characterized 389 female patients diagnosed in Hawaii with early stage breast cancer from 2003 to 2017 in the Multiethnic Cohort (MEC) linked with Kaiser Permanente Hawaii electronic medical record data. We evaluated weight changes from surgery to 4 years post-diagnosis with six time points along a patient’s treatment trajectory (chemotherapy, radiation, endocrine, or surgery alone) and annually thereafter, adjusting for age, race/ethnicity and initial body mass index (BMI). Results: We found key time points of significant weight change for breast cancer patients according to their adjuvant treatment. In patients who had surgery alone (S), surgery-radiation (SR), or surgery-endocrine therapy (SE), the majority of patients had stable weight, although this consistently decreased over time. However, the percentages of patients with weight loss and weight gain during this time steadily increased up to 4 years after initial surgery. Weight loss was more common than weight gain by about 2 fold in these treatment groups. For patients with surgery-chemotherapy (SC), there was significant weight loss seen within the first 3 months after surgery, during the time when patients receive chemotherapy. And this weight loss persisted until year 4. Weight gain was less commonly seen in this treatment group. Conclusions: We identified key time points during breast cancer treatment that may provide a therapeutic window to positively influence outcomes. Tailored weight management interventions should be utilized to promote overall health and long term survivorship.

1 December 2015 in Childhood Obesity
Verified
Journal Article
Closed access
COCaryn Etsuko Shima Oshiro
Caryn Etsuko Shima Oshiro
RNRachel Novotny
Rachel Novotny
JGJohn S. Grove
John S. Grove
EHEric L. Hurwitz
Eric L. Hurwitz
Background: Factors at birth and infancy may increase risk of being overweight in childhood. The aim of this study was to examine the relationship of birth size and infant growth (2–24 months) with BMI at age 5 years in a multiethnic population. Methods: This was a retrospective study (using electronic medical records of a health maintenance organization in Hawaii) of singleton children born in 2004–2005, with linked maternal and birth information, infant weights (n = 597) and lengths (n = 473) in the first 2 years, and BMI measures at age 5 years (n = 894). Multiple regression models were used to estimate the association of BMI at age 5 years with birth size and infant growth. Results: Birth weight was positively associated with BMI at age 5 years, adjusting for gestational age, sex, race/ethnicity, and maternal prepregnancy weight, age, education, and smoking. A greater change in infant weight was associated with a higher BMI at age 5 years, though the effect of birth weight on BMI was neither mediated nor modified by infant growth rate. Birth weight, change in infant weight, and BMI at age 5 years varied by race/ethnicity. Change in infant BMI in the first 2 years was higher in other Pacific Islanders and whites (Δ = 0.966; confidence interval [CI] = 0.249–1.684; p = 0.02) than in Asian, other, and part Native Hawaiian race/ethnic groups. Conclusions: Early biological measures of birth weight and infant weight gain varied by race/ethnicity and positively predicted BMI at age 5 years.

2 July 2021 in American Journal of Human Biology
Verified
Journal Article
Closed access
PDF file
COCaryn Etsuko Shima Oshiro
Caryn Etsuko Shima Oshiro
THTeresa A. Hillier
Teresa A. Hillier
GEGrant Edmonds
Grant Edmonds
MPMissy Peterson
Missy Peterson
PHPatrick L. Hill
Patrick L. Hill
SHSarah Hampson
Sarah Hampson